Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Prostap 3 DCS 11.25mg powder and solvent for prolonged-release suspension for injection pre-filled syringes (CST Pharma Ltd) |
| Virtual Medicinal Product | Leuprorelin 11.25mg powder and solvent for prolonged-release suspension for injection pre-filled syringes |
| Name | Prostap 3 DCS 11.25mg powder and solvent for prolonged-release suspension for injection pre-filled syringes |
| Abbreviated name | Prostap 3 DCS 11.25mg inj pre-filled syringes |
| Date of name applicability | 1 Dec 2024 |
| Previous name | Prostap 3 DCS 11.25mg powder and solvent for suspension for injection pre-filled syringes |
| Supplier | CST Pharma Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✓ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Licensed Route | |
| Licenced route | Subcutaneous |
| Actual Medicinal Product Packs | |
| Prostap 3 DCS 11.25mg powder and solvent for prolonged-release suspension for injection pre-filled syringes (CST Pharma Ltd) 1 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_10.2.0_20251020000001, imported on 20th October 2025 at 05:03:23.